Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.330
-0.050 (-1.48%)
Oct 9, 2026, 10:05 AM CST
Shenzhen Glory Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,812 | 3,082 | 2,599 | 3,430 | 3,928 | 4,806 | |
Market Cap Growth | -15.27% | 18.60% | -24.22% | -12.68% | -18.27% | -9.86% |
Enterprise Value | 2,268 | 2,529 | 2,114 | 2,940 | 3,669 | 4,656 |
Last Close Price | 3.38 | 3.65 | 3.07 | 4.05 | 4.64 | 5.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 116.64 | - | - | 107.94 |
Forward PE | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 |
PS Ratio | 2.56 | 2.86 | 1.80 | 2.88 | 3.08 | 2.68 |
PB Ratio | 1.10 | 1.18 | 0.94 | 1.25 | 1.31 | 1.40 |
P/TBV Ratio | 1.30 | 1.39 | 1.11 | 1.47 | 1.76 | 1.87 |
P/FCF Ratio | - | 205.42 | 66.98 | - | 100.33 | - |
P/OCF Ratio | 23.29 | 21.97 | 21.49 | 194.50 | 40.73 | 19.81 |
PEG Ratio | - | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.07 | 2.35 | 1.46 | 2.47 | 2.88 | 2.60 |
EV/EBITDA Ratio | - | - | 17.81 | - | - | 32.16 |
EV/EBIT Ratio | - | - | 129.91 | - | - | 68.36 |
EV/FCF Ratio | - | 168.58 | 54.48 | - | 93.71 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.10 | 0.11 | 0.11 | 0.11 |
Debt / EBITDA Ratio | - | - | 2.27 | - | - | 2.71 |
Debt / FCF Ratio | - | 2.67 | 6.94 | - | 8.48 | - |
Net Debt / Equity Ratio | -0.26 | -0.28 | -0.24 | -0.19 | -0.20 | -0.20 |
Net Debt / EBITDA Ratio | 8.52 | 11.47 | -5.69 | 34.12 | 52.96 | -4.81 |
Net Debt / FCF Ratio | 939.12 | -48.23 | -17.40 | 21.59 | -15.02 | 3.72 |
Asset Turnover | 0.33 | 0.30 | 0.37 | 0.29 | 0.28 | 0.36 |
Inventory Turnover | 4.76 | 4.17 | 3.79 | 2.63 | 2.73 | 4.17 |
Quick Ratio | 2.20 | 2.00 | 1.65 | 1.70 | 1.71 | 1.76 |
Current Ratio | 2.57 | 2.37 | 1.95 | 2.20 | 2.30 | 2.19 |
Return on Equity (ROE) | -5.79% | -5.42% | 0.94% | -5.60% | -10.20% | 2.07% |
Return on Assets (ROA) | -3.32% | -2.84% | 0.26% | -1.70% | -1.85% | 0.85% |
Return on Invested Capital (ROIC) | -9.41% | -8.21% | 0.58% | -4.81% | -5.29% | 2.40% |
Return on Capital Employed (ROCE) | -6.70% | -6.10% | 0.60% | -3.60% | -4.00% | 1.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -5.17% | -4.53% | 0.86% | -4.34% | -7.84% | 0.93% |
FCF Yield | -0.03% | 0.49% | 1.49% | -0.71% | 1.00% | -3.90% |
Dividend Yield | 0.24% | - | 0.26% | - | - | - |
Payout Ratio | - | - | 49.52% | - | - | 68.03% |
Buyback Yield / Dilution | 2.99% | 1.34% | -4.64% | -0.03% | 2.86% | -3.89% |
Total Shareholder Return | 3.23% | 1.34% | -4.38% | -0.03% | 2.86% | -3.89% |